HK1202137A1 - 分析細胞增殖性病症的方法和核酸 - Google Patents

分析細胞增殖性病症的方法和核酸

Info

Publication number
HK1202137A1
HK1202137A1 HK15102645.8A HK15102645A HK1202137A1 HK 1202137 A1 HK1202137 A1 HK 1202137A1 HK 15102645 A HK15102645 A HK 15102645A HK 1202137 A1 HK1202137 A1 HK 1202137A1
Authority
HK
Hong Kong
Prior art keywords
proliferative disorders
detecting
nucleic acids
methods
analyses
Prior art date
Application number
HK15102645.8A
Other languages
English (en)
Inventor
尤金．迪斯特勒
托馬斯．希爾德曼
拉爾夫．萊舍
卡西．洛夫頓-戴
法比安．莫德爾
馬蒂亞斯．許特爾
安德魯．希萊杰夫斯基
宋曉齡
雷莫．特茨納
Original Assignee
Epigenomics Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36746665&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1202137(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Epigenomics Ag filed Critical Epigenomics Ag
Publication of HK1202137A1 publication Critical patent/HK1202137A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15102645.8A 2005-04-15 2015-03-16 分析細胞增殖性病症的方法和核酸 HK1202137A1 (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US67224205P 2005-04-15 2005-04-15
US67699705P 2005-05-02 2005-05-02
US69752105P 2005-07-08 2005-07-08
US70486005P 2005-08-01 2005-08-01
US70931805P 2005-08-17 2005-08-17
US72360205P 2005-10-04 2005-10-04
US78740206P 2006-03-30 2006-03-30

Publications (1)

Publication Number Publication Date
HK1202137A1 true HK1202137A1 (zh) 2015-09-18

Family

ID=36746665

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15102645.8A HK1202137A1 (zh) 2005-04-15 2015-03-16 分析細胞增殖性病症的方法和核酸
HK18109906.4A HK1250521A1 (zh) 2005-04-15 2018-08-01 分析細胞增殖性病症的方法和核酸

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK18109906.4A HK1250521A1 (zh) 2005-04-15 2018-08-01 分析細胞增殖性病症的方法和核酸

Country Status (21)

Country Link
US (8) US7951563B2 (zh)
EP (4) EP2045335B1 (zh)
JP (2) JP5341506B2 (zh)
KR (3) KR20080011287A (zh)
CN (3) CN114921544A (zh)
AT (1) ATE410524T1 (zh)
AU (1) AU2006236620B2 (zh)
BR (1) BRPI0607508B8 (zh)
CA (1) CA2606296C (zh)
DE (1) DE602006003012D1 (zh)
DK (1) DK1721992T3 (zh)
EA (1) EA013634B1 (zh)
ES (2) ES2533767T3 (zh)
HK (2) HK1202137A1 (zh)
IL (1) IL186556A (zh)
MX (1) MX2007012782A (zh)
PL (1) PL1721992T3 (zh)
PT (1) PT1721992E (zh)
SG (1) SG183708A1 (zh)
SI (1) SI1721992T1 (zh)
WO (1) WO2006113466A2 (zh)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1668148B1 (en) 2003-09-04 2008-12-31 Human Genetic Signatures PTY Ltd. Nucleic acid detection assay
WO2006058393A1 (en) * 2004-12-03 2006-06-08 Human Genetic Signatures Pty Ltd Methods for simplifying microbial nucleic acids by chemical modification of cytosines
KR20080011287A (ko) * 2005-04-15 2008-02-01 에피제노믹스 아게 세포 증식 질환을 분석하기 위한 방법 및 핵산
EP1883707B1 (en) * 2005-05-26 2014-04-09 Human Genetic Signatures PTY Ltd Isothermal strand displacement amplification using primers containing a non-regular base
US8343738B2 (en) 2005-09-14 2013-01-01 Human Genetic Signatures Pty. Ltd. Assay for screening for potential cervical cancer
ES2587068T3 (es) * 2006-04-17 2016-10-20 Epigenomics Ag Métodos y ácidos nucleicos para la detección de desórdenes celulares proliferativos colorrectales
US20080050738A1 (en) * 2006-05-31 2008-02-28 Human Genetic Signatures Pty Ltd. Detection of target nucleic acid
WO2008011620A2 (en) * 2006-07-21 2008-01-24 Epigenomics Ag Methods and nucleic acids for analyses of cellular proliferative disorders
CN101153336B (zh) 2006-09-27 2011-09-07 香港中文大学 检测dna甲基化程度的方法和试剂盒
US7662566B2 (en) * 2006-11-22 2010-02-16 Myriad Genetics, Inc. Gene copy number profiling
US20080221056A1 (en) * 2007-02-12 2008-09-11 Johns Hopkins University Early Detection and Prognosis of Colon Cancers
EP2126120A4 (en) * 2007-03-16 2011-03-30 Human Genetic Signatures Pty Gene Expression Test Methods
WO2008122447A2 (en) * 2007-04-10 2008-10-16 Epigenomics Ag Dna methylation assay for the diagnosis or prognosis of medical conditions
DK2479289T3 (en) * 2007-06-08 2016-05-02 Epigenomics Ag Method for methylation analysis
FR2919061B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal.
CA2706740C (en) 2007-11-27 2017-01-17 Human Genetic Signatures Pty Ltd Enzymes for amplification and copying bisulphite modified nucleic acids
JP5694776B2 (ja) * 2007-12-11 2015-04-01 エピゲノミクス アーゲー 細胞増殖性障害の解析のための方法及び核酸
WO2009079703A1 (en) * 2007-12-20 2009-07-02 Human Genetic Signatures Pty Ltd Elimination of contaminants associated with nucleic acid amplification
TW200927925A (en) * 2007-12-27 2009-07-01 Agriculture And Food Agency Council Of Agriculture Specific Promoter Region Expresses in Actively Dividing Young Tissues and the Aging Tissues in Plants and its Application
US20110245087A1 (en) * 2008-03-18 2011-10-06 Gunter Weiss Method for optimizing and validating an assay for determining the presence or absence of a medical condition
US20110195070A1 (en) * 2008-10-09 2011-08-11 British Columbia Cancer Agency Branch Detection of granulosa-cell tumors
EP2309005B1 (en) * 2009-08-03 2015-03-04 Epigenomics AG Methods for preservation of genomic DNA sequence complexity
TWI434937B (zh) * 2009-10-28 2014-04-21 Univ Nat Chunghsing 具有廣泛性抗木瓜輪點病毒特性的基因轉殖木瓜品系１８－２－４之核酸分子及其檢測方法及應用
GB201004147D0 (en) * 2010-03-12 2010-04-28 Dna Electronics Ltd Method and apparatus for sensing methylation
KR101747191B1 (ko) 2011-01-14 2017-06-14 에스케이하이닉스 주식회사 반도체 장치
GB201107466D0 (en) 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
WO2012167145A2 (en) * 2011-06-01 2012-12-06 University Of Southern California Genome-scale analysis of aberrant dna methylation in colorectal cancer
FI20115709A0 (fi) * 2011-07-01 2011-07-01 Helsingin Yliopisto Menetelmä perinnöllisten syöpien diagnosointiin
CN103732759A (zh) * 2011-07-08 2014-04-16 表观基因组股份有限公司 用于确定癌症对象之预后的方法和核酸
EP2753710B1 (en) 2011-09-07 2017-01-11 Human Genetic Signatures Pty Ltd Molecular detection assay
US9546403B1 (en) 2011-12-14 2017-01-17 University Of Utah Research Foundation Substrate for methylated DNA testing
EP2828405B1 (en) * 2012-03-20 2017-06-28 Exact Sciences Corporation Marker panel for detecting cancer
AU2012388616A1 (en) * 2012-08-31 2015-04-02 National Defense Medical Center Method for screening cancer
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
KR101476769B1 (ko) * 2013-01-02 2014-12-26 대구대학교 산학협력단 leucine-richα-2 glyprotein를 함유하는 대장암 진행예측용 바이오마커 조성물 및 이를 포함하는 대장암 진단용 바이오키트
JP6369857B2 (ja) * 2013-05-29 2018-08-08 シスメックス株式会社 肝細胞癌に関する情報の取得方法、ならびに肝細胞癌に関する情報を取得するためのマーカーおよびキット
KR101527283B1 (ko) * 2013-08-13 2015-06-10 서울대학교산학협력단 당단백질의 탈당화 검출을 통한 암 마커 스크리닝 방법 및 간세포암 마커
KR101438519B1 (ko) * 2014-07-01 2014-09-17 대구대학교 산학협력단 complement factor B를 함유하는 대장암 진행예측용 바이오마커 조성물 및 이를 포함하는 대장암 진단용 바이오키트
EP3164039B1 (en) 2014-07-03 2018-06-13 Aktiebolaget Electrolux Household appliance mixing arrangement
CN106455585A (zh) 2014-07-03 2017-02-22 伊莱克斯公司 家用电器搅拌装置
TWI813141B (zh) 2014-07-18 2023-08-21 香港中文大學 Ｄｎａ混合物中之組織甲基化模式分析
CN104745575B (zh) * 2014-08-08 2019-03-12 博诚研究中心 用于检测细胞增殖性异常或疾病程度分级的基因组合物及其用途
US20180143198A1 (en) * 2014-12-26 2018-05-24 Peking University Method for detecting differentially methylated cpg islands associated with abnormal state of human body
CN115181802A (zh) * 2015-04-23 2022-10-14 博尔诚（北京）科技有限公司 一种检测Septin9基因甲基化的试剂盒及其应用
CN104830855A (zh) * 2015-05-21 2015-08-12 基因科技（上海）有限公司 一种检测sept9基因甲基化的探针及其应用
RU2630669C1 (ru) * 2016-07-21 2017-09-11 Федеральное бюджетное учреждение науки "Государственный научный центр вирусологии и биотехнологии "Вектор" (ФБУН ГНЦ ВБ "Вектор") Способ определения метилирования сайтов PuCGPy регуляторных областей генов-онкомаркеров колоректального рака методом GLAD-ПЦР-анализа и набор олигонуклеотидных праймеров и флуоресцентно-меченых зондов для осуществления указанного способа
CN109804086B (zh) 2016-08-10 2023-06-13 格里尔公司 制备双标签dna库用于亚硫酸盐转化定序的方法
CN107723363A (zh) * 2016-08-11 2018-02-23 博尔诚（北京）科技有限公司 肿瘤标志物的组合检测方法及其应用
CA3039685A1 (en) 2016-11-30 2018-06-07 The Chinese University Of Hong Kong Analysis of cell-free dna in urine and other samples
EP3360971A1 (en) * 2017-02-09 2018-08-15 Epiontis GmbH Improved method for epigenetic immune cell counting
AU2018256387A1 (en) 2017-04-19 2019-10-31 Singlera Genomics, Inc. Compositions and methods for library construction and sequence analysis
CN109609629A (zh) * 2017-09-30 2019-04-12 博尔诚（北京）科技有限公司 用于检测肝癌的组合物及其用途
CN108866192B (zh) * 2018-07-26 2021-06-22 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep1
CN108866191B (zh) * 2018-07-26 2021-07-09 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep2
AU2019351130A1 (en) 2018-09-27 2021-04-08 Grail, Llc Methylation markers and targeted methylation probe panel
CN116064815A (zh) * 2019-02-14 2023-05-05 博尔诚（北京）科技有限公司 一种食管癌、胃癌、肠癌、肝癌和/或胰腺癌患癌、癌前筛查组合物及其用途
CN110211633B (zh) * 2019-05-06 2021-08-31 臻和精准医学检验实验室无锡有限公司 Mgmt基因启动子甲基化的检测方法、测序数据的处理方法及处理装置
CN112063712A (zh) * 2019-10-28 2020-12-11 北京康美天鸿生物科技有限公司 基于高分辨率熔解曲线检测septin9基因甲基化的特异引物对和试剂盒
MX2022007434A (es) * 2019-12-16 2022-09-19 Epigenomics Ag Metodos para detectar el cancer colorrectal.
WO2023017001A1 (en) 2021-08-09 2023-02-16 Epigenomics Ag Improved methods for detecting colorectal cancer
CN113584032B (zh) * 2021-08-20 2023-08-29 深圳市恩辑生物科技有限公司 一种迷你启动子pAPP及其应用
CN113862349A (zh) * 2021-10-26 2021-12-31 山东师范大学 一种肺纤维化诊断生物标志物
WO2024074558A1 (en) 2022-10-04 2024-04-11 Epigenomics Ag Improved methods for detecting cancer

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585481A (en) 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
US5457183A (en) 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5245022A (en) 1990-08-03 1993-09-14 Sterling Drug, Inc. Exonuclease resistant terminally substituted oligonucleotides
US5565552A (en) * 1992-01-21 1996-10-15 Pharmacyclics, Inc. Method of expanded porphyrin-oligonucleotide conjugate synthesis
US5574142A (en) * 1992-12-15 1996-11-12 Microprobe Corporation Peptide linkers for improved oligonucleotide delivery
SE501439C2 (sv) 1993-06-22 1995-02-13 Pharmacia Lkb Biotech Sätt och anordning för analys av polynukleotidsekvenser
ATE178939T1 (de) 1993-11-30 1999-04-15 Univ Mcgill Dna methyltransferase inhibierung
US5597696A (en) * 1994-07-18 1997-01-28 Becton Dickinson And Company Covalent cyanine dye oligonucleotide conjugates
US5514758A (en) 1994-09-30 1996-05-07 The Goodyear Tire & Rubber Company Process for making latex for high performance masking tape
US5871917A (en) 1996-05-31 1999-02-16 North Shore University Hospital Research Corp. Identification of differentially methylated and mutated nucleic acids
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US5786146A (en) * 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
JPH1090169A (ja) 1996-09-19 1998-04-10 Bunshi Bio Photonics Kenkyusho:Kk 顕微鏡装置
CZ297640B6 (cs) 1996-10-01 2007-02-21 Molekula izolované nukleové kyseliny kódující polypeptidy a zpusob jejího použití
US6251594B1 (en) 1997-06-09 2001-06-26 Usc/Norris Comprehensive Cancer Ctr. Cancer diagnostic method based upon DNA methylation differences
DE19754482A1 (de) 1997-11-27 1999-07-01 Epigenomics Gmbh Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke
GB9726539D0 (en) 1997-12-16 1998-02-11 Univ Dundee Polypeptides, polynucleotides and uses thereof
GB9805918D0 (en) * 1998-03-19 1998-05-13 Nycomed Amersham Plc Sequencing by hybridisation
AUPP312998A0 (en) * 1998-04-23 1998-05-14 Commonwealth Scientific And Industrial Research Organisation Diagnostic assay
US7700324B1 (en) 1998-11-03 2010-04-20 The Johns Hopkins University School Of Medicine Methylated CpG island amplification (MCA)
US5958773A (en) * 1998-12-17 1999-09-28 Isis Pharmaceuticals Inc. Antisense modulation of AKT-1 expression
JP2000221136A (ja) 1999-01-29 2000-08-11 Jasco Corp 経時変化追跡方法および装置
US6331393B1 (en) * 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6783933B1 (en) * 1999-09-15 2004-08-31 The Johns Hopkins University School Of Medicine CACNA1G polynucleotide, polypeptide and methods of use therefor
WO2001029254A2 (en) * 1999-10-19 2001-04-26 Universiteit Gent Identification of bpesc1, a gene disrupted by a balanced chromosomal translocation t(3;4) (q23;p15.2) in a patient with bpes
JP3783826B2 (ja) 2000-01-17 2006-06-07 横河電機株式会社 バイオチップ読み取り装置
WO2005000087A2 (en) * 2003-06-03 2005-01-06 Chiron Corporation Gene products differentially expressed in cancerous colon cells and their methods of use ii
EA007028B1 (ru) * 2000-09-01 2006-06-30 Эпигеномикс Аг Метод определения степени метилирования специфических цитозинов в геномной днк в контексте последовательности 5'-cpg-3'
US6756200B2 (en) * 2001-01-26 2004-06-29 The Johns Hopkins University School Of Medicine Aberrantly methylated genes as markers of breast malignancy
DE10112515B4 (de) * 2001-03-09 2004-02-12 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität
US7473767B2 (en) * 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
JP2005515787A (ja) * 2001-10-18 2005-06-02 ラブレイス レスピレイトリー リサーチ インスティチュート 転写因子遺伝子ＰＡＸ５α、ＰＡＸ５β、新規ループヘリックスループタンパク質、新規遺伝子２、およびベータ３遺伝子のプロモーターの異常メチル化による癌のモニタリング
WO2003042661A2 (en) * 2001-11-13 2003-05-22 Protein Design Labs, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
JP3448654B2 (ja) 2001-11-22 2003-09-22 北陸先端科学技術大学院大学長 バイオチップ、バイオチップアレイ、及びそれらを用いたスクリーニング方法
EP3098231A1 (en) 2001-11-30 2016-11-30 The John Hopkins University Methods for analyzing methylated cpg islands and gc rich regions
JP2003232725A (ja) 2002-02-12 2003-08-22 Japan Science & Technology Corp 表面プラズモン共鳴測定法を用いる化学反応解析センサ
DE10228917A1 (de) 2002-06-24 2004-01-22 Epigenomics Ag Vorrichtung zur Handhabung von Flüssigkeiten in einer Mehrzahl von Kanälen
JP4199609B2 (ja) 2002-07-12 2008-12-17 三菱化学株式会社 分析用チップ、分析用チップユニット及び分析装置ならびに分析用チップの作製方法
DK1525188T3 (da) 2002-07-16 2008-11-17 Inst Nat Sante Rech Med Hidtil ukendte derivater af 4,4-dithiobis-(3-aminobutan-1-sulfonater) og sammensætninger, der indeholder dem
WO2004035803A2 (en) 2002-10-01 2004-04-29 Epigenomics Ag Method and nucleic acids for the treatment of breast cell proliferative disorders
DE10317955A1 (de) 2003-04-17 2004-11-25 Epigenomics Ag Verfahren und Nukleinsäuren für die verbesserte Behandlung von proliferativen Erkrankungen von Brustzellen
US20060024684A1 (en) 2002-10-01 2006-02-02 Epigenomics Ag Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients
DE10245779A1 (de) 2002-10-01 2004-04-29 Epigenomics Ag Verfahren und Nukleinsäuren für die verbesserte Behandlung von proliferativen Erkrankungen von Brustzellen
JP2004156911A (ja) 2002-11-01 2004-06-03 Osaka Industrial Promotion Organization 表面プラズモン蛍光顕微鏡、および表面プラズモンにより励起された蛍光を測定する方法
JP2004212204A (ja) 2002-12-27 2004-07-29 Olympus Corp 蛍光顕微鏡及び蛍光寿命の測定方法、並びに蛍光寿命の測定用プログラム
WO2004074441A2 (en) * 2003-02-19 2004-09-02 Government Of The United States Of America Represented By The Secretary Department Of Health And Human Services Amplification or overexpression of mll septin-like fusion (msf) and septin9 and methods related thereto
US20040265833A1 (en) * 2003-06-23 2004-12-30 Cathy Lofton-Day Methods and nucleic acids for the analysis of colorectal cell proliferative disorders
EP1636386B1 (en) 2003-06-23 2015-08-05 Epigenomics AG Methods and nucleic acids for analyses of colorectal cell proliferative disorders
EP2292797B1 (en) 2003-10-09 2013-07-24 Epigenomics AG Improved bisulfite conversion of DNA
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
US20050152908A1 (en) 2003-11-03 2005-07-14 Genenews Inc. Liver cancer biomarkers
WO2005054517A2 (en) 2003-12-01 2005-06-16 Epigenomics Ag Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
EP1692316A2 (en) 2003-12-11 2006-08-23 Epigenomics AG Method and nucleic acids for the improved treatment of breast cell proliferative disorders
EP1561821B1 (en) 2003-12-11 2011-02-16 Epigenomics AG Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients
EP1756311A2 (en) 2004-05-17 2007-02-28 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin Silencing of tumor-suppressive genes by cpg-methylation in prostate cancer
DE102004029700A1 (de) 2004-06-15 2006-02-09 Epigenomics Ag Verfahren zur Quantifizierung methylierter DNA
WO2005123945A2 (en) 2004-06-21 2005-12-29 Epigenomics Ag Epigenetic markers for the treatment of breast cancer
EP2281902A1 (en) * 2004-07-18 2011-02-09 Epigenomics AG Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders
JP4192862B2 (ja) 2004-07-20 2008-12-10 ダイソー株式会社 ポリエーテル系共重合体の製造方法
CA2589782A1 (en) 2004-11-30 2006-06-08 Veridex Llc Lung cancer prognostics
EP1831399B1 (en) * 2004-12-02 2009-08-05 Epigenomics AG Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders
KR20080011287A (ko) * 2005-04-15 2008-02-01 에피제노믹스 아게 세포 증식 질환을 분석하기 위한 방법 및 핵산
US20090005268A1 (en) 2005-07-18 2009-01-01 Epigenomics Ag Compositions and Methods for Cancer Diagnostics Comprising Pan-Cancer Markers
WO2007115213A2 (en) 2006-03-30 2007-10-11 Epigenomics Ag Methods and nucleic acids for analyses of cellular proliferative disorders
ES2587068T3 (es) 2006-04-17 2016-10-20 Epigenomics Ag Métodos y ácidos nucleicos para la detección de desórdenes celulares proliferativos colorrectales

Also Published As

Publication number Publication date
EP1877577A2 (en) 2008-01-16
US11186879B2 (en) 2021-11-30
EA200702203A1 (ru) 2008-04-28
DK1721992T3 (da) 2009-02-02
ES2533767T3 (es) 2015-04-15
AU2006236620A1 (en) 2006-10-26
KR20130021400A (ko) 2013-03-05
US7749702B2 (en) 2010-07-06
ES2315956T3 (es) 2009-04-01
EP1721992A3 (en) 2006-12-20
US20090075260A1 (en) 2009-03-19
CN114921544A (zh) 2022-08-19
BRPI0607508B8 (pt) 2021-07-27
US9695478B2 (en) 2017-07-04
EP2009115A2 (en) 2008-12-31
CN107663538A (zh) 2018-02-06
US8900829B2 (en) 2014-12-02
EA013634B1 (ru) 2010-06-30
CN104046686A (zh) 2014-09-17
CA2606296A1 (en) 2006-10-26
HK1250521A1 (zh) 2018-12-21
EP2009115A3 (en) 2009-02-25
CA2606296C (en) 2019-05-21
DE602006003012D1 (de) 2008-11-20
US20220154287A1 (en) 2022-05-19
CN104046686B (zh) 2017-07-28
AU2006236620B2 (en) 2012-02-23
US10385402B2 (en) 2019-08-20
SG183708A1 (en) 2012-09-27
EP1721992A2 (en) 2006-11-15
IL186556A (en) 2014-05-28
US20190316210A1 (en) 2019-10-17
BRPI0607508A2 (pt) 2009-09-15
PT1721992E (pt) 2009-01-14
WO2006113466A8 (en) 2012-04-12
JP2013090629A (ja) 2013-05-16
KR20150006089A (ko) 2015-01-15
WO2006113466A2 (en) 2006-10-26
JP5341506B2 (ja) 2013-11-13
KR20080011287A (ko) 2008-02-01
US20150086989A1 (en) 2015-03-26
ATE410524T1 (de) 2008-10-15
MX2007012782A (es) 2008-03-14
SI1721992T1 (sl) 2009-04-30
EP2045335A1 (en) 2009-04-08
JP5808306B2 (ja) 2015-11-10
IL186556A0 (en) 2008-01-20
US20110244458A1 (en) 2011-10-06
EP2045335B1 (en) 2014-12-31
US20060286576A1 (en) 2006-12-21
US20160304964A1 (en) 2016-10-20
WO2006113466A3 (en) 2007-01-18
JP2008538497A (ja) 2008-10-30
PL1721992T3 (pl) 2009-04-30
KR101708544B1 (ko) 2017-02-20
CN107663538B (zh) 2022-03-18
EP1721992B1 (en) 2008-10-08
BRPI0607508B1 (pt) 2021-01-12
US20110039719A1 (en) 2011-02-17
US7951563B2 (en) 2011-05-31

Similar Documents

Publication Publication Date Title
HK1250521A1 (zh) 分析細胞增殖性病症的方法和核酸
IL233548A0 (en) Methods and nucleic acids for the diagnosis of disorders in the development of cells
WO2007118704A3 (en) Methods and nucleic acids for the detection of colorectal cell proliferative disorders
WO2006034879A3 (en) Epigenetic methods and nucleic acids for the detection of lung cell proliferative disorders
HK1142638A1 (zh) 選擇性地擴增、檢測或定量低甲基化靶 的方法
WO2009074328A8 (en) Methods and nucleic acids for analyses of lung carcinoma
WO2005001141A8 (en) Methods and nucleic acids for analyses of colorectal cell proliferative disorders
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
WO2008008983A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
WO2008011620A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
WO2010007083A3 (en) Methods and nucleic acids for analyses of cell proliferative disorders
WO2007115213A3 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
WO2009065511A3 (en) Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
WO2009092597A3 (en) Methods and nucleic acids for analyses of prostate cancer
WO2005001140A3 (en) Methods and nucleic acids for the analysis of colon cell proliferative disorders
WO2010099378A3 (en) Assay for detection of human parvovirus nucleic acid
WO2004096021A3 (en) Global analysis of transposable elements as molecular markers of cancer

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230415